Design of naltrexone-loaded hydrolyzable crosslinked nanoparticles

International Journal of Pharmaceutics

Volumn 244, Issue 1-2, 2002, Pages 9-19

  Yin, Wusheng ^a   Akala, Emmanuel O ^a   Taylor, Robert E ^b  

^a HOWARD UNIVERSITY   (United States)

^b HOWARD UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Drug delivery system; Hydrolyzable crosslinked copolymer; Naltrexone; Nanoparticles

Indexed keywords

ACAMPROSATE; DISULFIRAM; ETHER; HYDROXYLAMINE; MACROGOL; METHACRYLIC ACID DERIVATIVE; METHACRYLIC ACID METHYL ESTER; N,O DIMETHACRYLOYLHYDROXYLAMINE; NALTREXONE; NANOPARTICLE; NARCOTIC ANTAGONIST; POLYETHYLENE GLYCOL MONOMETHYL ETHER MONOMETHACRYLATE; POLYVINYL ALCOHOL; UNCLASSIFIED DRUG;

ANALYTIC METHOD; AQUEOUS SOLUTION; ARTICLE; CROSS LINKING; DRUG BIOAVAILABILITY; DRUG DESIGN; DRUG MECHANISM; HYDROLYSIS; IN VITRO STUDY; INFRARED SPECTROSCOPY; MELTING POINT; MICROPHOTOGRAPHY; PARTICLE SIZE; POLYMERIZATION; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SUSTAINED DRUG RELEASE; SYNTHESIS; TRANSMISSION ELECTRON MICROSCOPY;

CHEMISTRY, PHARMACEUTICAL; CROSS-LINKING REAGENTS; DRUG DELIVERY SYSTEMS; NALTREXONE; SPECTROSCOPY, FOURIER TRANSFORM INFRARED;

EID: 0037026272     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(02)00297-1     Document Type: Article

References (27)

1. Akala E.O. Hydrolysis of linear copolymers containing N,O-dacylhydroxylamine moiety. Pharm. Pharmacol. Lett. 8:1998;129-132.
2. Akala E.O., Kopeckova P., Kopecek J. Novel pH-sensitive hydrogels with adjustable swelling kinetics. Biomaterials. 19:1998;1037-1047.
3. Allen C., Yu Y., Maysinger D., Eisenberg A. Polycaprolactone-b-poly(ethylene oxide) block copolymer micelles as a novel drug delivery vehicle for neurotrophic agents FK506 and L-685818. Bioconjugate Chem. 9:1998;564-572.
4. Birrenbach G., Speiser P.P. Polymerized micelles and their use as adjuvants in immunology. J. Pharm. Sci. 65:1976;1763-1766.
5. Fattal E., Couvreur P. Polymeric nanoparticles and microparticles as carriers for antisense oligonucleotides. Couvreur P., Malvy C., Pharmaceutical Aspects of Oligonucleotides. 2000;128-145 Taylor & Francis, London.
6. Fuller R.K., Hiller-Sturmhofel S. Alcoholism treatment in the United States: an overview. Alcohol Res. Health. 23:1999;69-77.
7. Gref R., Minamitake Y., Peracchia M.T., Trubetskoy V., Torchilin V., Langer R. Biodegradable long-circulating polymeric nanospheres. Science. 263:1994;1600-1603.
8. Ichikawa H., Peppas N.A. pH-dependent swelling of nano-sized poly(methacrylic acid-g-ehtylene glycol) gels. Polymer Preprints. 40:1999;363-364.
9. Jaeghere F.D., Doelker E., Gurny R. Nanoparticles. Mathiowitz E., Encyclopedia of Controlled Drug Delivery. 2:1999;641-664 Wiley, New York.
10. Johnson D.A.W. Observations on the use of long-acting depot neuroleptic injections in the maintenance therapy of schizopherenia. J. Clin. Psychiatry. 5:1984;13-21.
11. Johnson B.A., Ait-Daoud N. Medications to treat alcoholism. Alcohol Res. Health. 23:1999;99-105.
12. Kranzler H.R. Pharmacotherapy of alcoholism: gaps in knowledge and opportunities for research. Alcohol Alcohol. 35:(6):2000;537-547.
13. Kratochvil P. Huglin M.B., Light Scattering from Polymer Solutions. 1972;339-340 Academic Press, New York.
14. Kreuter J. Nanoparticles. Swarbrick J., Boylan J.C., Encyclopedia of Pharmaceutical Technology. 10:1994;165-190 Marcel Dekker, New York.
15. Litten R.Z., Allen J., Fertig J. Pharmacotherapies for alcohol problems: a review of research with focus on developments since 1991. Alcohol. Clin. Exp. Res. 20:1996;859-876.
16. Paille F.M., Guelfi J.D., Perkins A.C., Royer R.J., Steru L., Parot P. Double blind randomized multicenter trial of acamprosate in maintaining abstinence from alcohol. Alcohol Alcohol. 30:1995;239-247.
17. Roessner D., Kulickle W. On-line coupling of flow field-flow fractionation and multi-angle laser light scattering. J. Chromatogr. A. 687:1994;249-258.
18. Seijo B., Fattal E., Roblot-Treupel L., Couvreur P. Design of nanoparticles of less than 50 nm diameter: preparation, characterization and drug loading. Int. J. Pharmaceutics. 62:1990;1-7.
19. Swift R.M. Drug therapy for alcohol dependence. New Engl. J. Med. 340:1999;1482-1490.
20. Thrumond K.B., Kowalewski T., Wolley K.L. Shell cross-linked knedels: a synthetic study of the factors affecting the dimensions and properties of amphiphilic core-shell nanospheres. J. Am. Chem. Soc. 119:1997;6656-6665.
21. Ulbrich K., Subr V., Seymour L.W., Duncan R. Novel biodegradable hydrogels prepared using divinyl crosslinking agent N,O-dimethacryloylhydroxylamine 1. Synthesis and characterization of rates of gel degradation and rate of release of model drugs in vitro and in vivo. J. Control. Release. 24:1993;181-190.
22. Wall M.E., Brine D.R., Perez-Reyes M. Metabolism and disposition of naltrexone in man after oral and intravenous administration. Drug Metab. Dispos. 9:1981;370-375.
23. Weinreb R.M., O'Brien C.P. Naltrexone in the treatment of alcoholism. Annu. Rev. Med. 48:1997;477-487.
24. Won Y.-Y., Davis H.T., Bates F.S. Giant wormlike rubber micelles. Science. 283:1999;960-963.
25. Wyatt P.J. Light scattering and the absolute characterization of macromolecules. Anal. Chim. Acta. 272:1993;1-40.
26. Wyatt P.J. Submicrometer particle sizing by multipleangle light scattering following fractionation. J. Colloid Interf. Sci. 197:1998;9-20.
27. Zhang L., Eisenberg A. Multiple morphologies of 'crew-cut' aggregates of polystyrene-b-poly(acrylic acid) block copolymers. Science. 268:1995;1728-1731.